Intal and Urinary retention - a phase IV clinical study of FDA data

Summary:

Urinary retention is reported as a side effect among people who take Intal (cromolyn sodium), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Oxycontin, and have Narcolepsy.

The phase IV clinical study analyzes which people have Urinary retention when taking Intal. It is created by eHealthMe based on reports of 1,614 people who have side effects when taking Intal from the FDA, and is updated regularly.

What is Intal?

Intal has active ingredients of cromolyn sodium. It is often used in asthma. eHealthMe is studying from 1,621 Intal users. Check the latest studies of Intal.

What is Urinary retention?

Urinary retention (the inability to completely or partially empty the bladder) is found to be associated with 1,567 drugs and 1,741 conditions by eHealthMe. Check the latest studies of Urinary retention.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

1,614 people reported to have side effects when taking Intal.
Among them, 15 people (0.93%) have Urinary retention.

Among these 15 people:

How long have people been on Intal when they have Urinary retention? *

What is the gender of people who have Urinary retention when taking Intal? *

female: 78.57 %
male: 21.43 %

What is the age of people who have Urinary retention when taking Intal? *

What are other drugs people take besides Intal? *

Mobic: 7 people, 46.67%
Xyrem: 7 people, 46.67%
Arformoterol Tartrate: 7 people, 46.67%
Qvar: 7 people, 46.67%
Soma: 7 people, 46.67%
Drisdol: 7 people, 46.67%
Hydrocodone Bitartrate And Acetaminophen: 7 people, 46.67%
Oxycontin: 7 people, 46.67%
Spiriva: 3 people, 20.00%
Neurontin: 3 people, 20.00%

What are other side effects people have besides Urinary retention? *

Fatigue (feeling of tiredness): 10 people, 66.67%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 8 people, 53.33%
Spinal Cord Trauma: 8 people, 53.33%
Vocal Cord Disorder: 8 people, 53.33%
Exostosis (formation of new bone on the surface of a bone): 8 people, 53.33%
Tooth Disorder (tooth disease): 8 people, 53.33%
Autonomic Neuropathy (malfunction of the autonomic nervous system (ans)): 8 people, 53.33%
Carpal Tunnel Syndrome (nerve compression at wrist results numbness weakness, pain , swelling): 8 people, 53.33%
Bladder Spasm: 8 people, 53.33%
Pain: 7 people, 46.67%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 53.33%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 7 people, 46.67%
Renal Tubular Acidosis (medical condition that involves an accumulation of acid in the body due to a failure of the kidneys): 2 people, 13.33%
Pain: 2 people, 13.33%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 2 people, 13.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 13.33%
Fever: 2 people, 13.33%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 2 people, 13.33%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 13.33%
Cerebral Palsy: 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Intal and have Urinary retention?

- Check whether Urinary retention is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Intal:

Intal (1,621 reports)

Browse all side effects of Intal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urinary retention:

Urinary retention (1,567 drugs)

Browse all the conditions that are associated with Urinary retention:

Urinary retention (1,741 conditions)

Related publications that referenced our studies

Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .

How the study uses the data?

The study uses data from the FDA. It is based on cromolyn sodium (the active ingredients of Intal) and Intal (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.